Customization of therapy for gastroesophageal adenocarcinoma patients

Gastroesophageal adenocarcinomas (GEACs) remain a global health problem. These are most often diagnosed at advanced stage and the estimated 5-year relative survival rate is about 5%. Although cure is not possible for patients with advanced GEAC, systemic therapy (chemotherapy or biochemotherapy) can...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dilsa Mizrak Kaya, Kazuto Harada, Fatemeh G. Amlashi, Maria Vasilakopoulou, Jaffer A. Ajani
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2018
Materias:
Acceso en línea:https://doaj.org/article/67582d5f1347400690565480df29ae11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!